School vaccine campaigns come under scrutiny in France after 12-year-old boy dies on school floor following HPV shot


Despite there being multiple court cases in the U.S., India, Japan, Colombia, Spain and France proving the HPV vaccine to be an instrument of death and debilitation, pharmaceutical companies and multinational organizations continue to fund HPV vaccine campaigns in school systems around the world.

A nationwide HPV vaccine campaign was launched in French schools on October 19, 2023. The vaccine campaign targeted schoolchildren ages 11-14. Not only did the toxic, aluminum-based injection poison every single student injected, but the vaccine program also went on to cause the death of a 12-year-old boy named Elouan.

12-year-old boy’s death following Gardasil vaccine prompts nationwide outcry

The young Elouan collapsed just minutes after receiving Gardasil’s HPV vaccine at Saint-Dominique College, a private school in Saint-Herblain near Nantes. Upon collapsing, the boy suffered head trauma and was taken to the Nantes University hospital. At the hospital, his condition worsened, and he passed away on October 27th.

The Regional Health Authority of Pays de la Loire (ARS) reported that Elouan “fell heavily to the floor” after receiving the vaccination, with the back of his head striking the “hard surface” in the room where the vaccination took place.

ARS reported: “Despite the intervention” of the nurses present, Elouan’s “condition deteriorated in the following days in relation to the severity of his head trauma.”

These tragic events prompted an investigation by the Nantes public prosecutor’s office. Prosecutor Renaud Gaudeul seeks to “determine whether the medical treatment of this minor — before, during and after the injection — was carried out according to the rules of the art.” Gaudeul told Ouest France, “We want to understand how a young boy could have died in these circumstances.” Those involved are being investigated for involuntary manslaughter.

Brighteon.TV

French health officials dismiss the obvious, protecting the deceptive HPV vaccine racket

The ARS, on the other hand, immediately denied any connection between the boy’s death and the vaccine. The ARS claimed that malaise can occur from stress induced by getting vaccinated. The ARS claimed that the boy’s malaise and syncope could not be related to the vaccine, nor could it be related to a quality defect of the pharmaceutical product. The hasty ARS response highlights the government’s tendency to overlook obvious circumstantial evidence to coverup vaccine injuries and conceal any further acts of medical malfeasance.

ARS’s dismissal of life-threatening vaccine injuries is modeled after the World Health Organization’s definition of syncope following vaccination. The WHO acknowledges that fainting is a potential adverse event of vaccination, but they define this problem as “temporary loss of consciousness with a quick recovery” that is an “immunization stress-related response.” In other words, the WHO claims that fainting or syncope is of psychological origin, and not the fault of the vaccine itself.

The French Minister of Health, Aurélien Rousseau, has already dismissed the boy’s case. He told the French National Assembly that Elouan’s “malaise” is “the main adverse effect of any form of vaccination” and had “no link with the injected product.”

“Everything will obviously be examined and made public,” Rousseau said. “As I speak to you, approximately 20,000 doses have been injected. This is the only serious, tragic adverse event that we have had to experience.” However, this is not true. In the U.S. alone, the Vaccine Injury Compensation Program has paid more than $70 million in damages to children injured by Gardasil.

Are French prosecutors preparing to hold the vaccine industry accountable for killing children?

Syncope is just one of many serious adverse events of HPV vaccines. According to Rosenberg, the Gardasil vaccine is associated with “autoimmune diseases and disorders, dysautonomia, neurological disorders, reproductive disorders and more” including but not limited to: chronic fatigue and chronic pain syndrome, fibromyalgia, Guillain-Barré syndrome, immune thrombocytopenia, lupus, postural orthostatic tachycardia syndrome, small fiber neuropathy and death.

Despite these callous dismissals by public health officials, the prosecutor’s office is pressing forward with an investigation, looking into the conditions under which the vaccine was administered; the medical supervision of the child; and the conditions for medical care of the child after the life-threatening injury occurred. According to a French parent, the vaccination days were announced in March 2023 and were carried out on October 2nd by mobile teams with/without a doctor present.

Didier Lambert, president of the Mutual Aid Association for Macrophage Myofascitis Sufferers (E3M), spoke about his investigation in an interview with Nexus. Lambert said E3M “filed a request to investigate the presence of aluminum and/or HPV DNA in [Elouan’s] brain,” and that E3M had been asking “for a moratorium on HPV vaccination in middle schools for several months.” Lambert is also pressing the public prosecutor to conduct an autopsy that searches for HPV DNA fragments and aluminum adjuvant.

However, the vaccination campaign continues, despite growing public opposition.

Sources include:

Business-HumanRights.org

ChildrensHealthDefense.org

Ouest-France.fr

WHO.int

Bloomberg.com

Nexus.fr

ChildrensHealthDefense.org [PDF]


Submit a correction >>

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.


Comments
comments powered by Disqus

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.

RECENT NEWS & ARTICLES

Get the world's best independent media newsletter delivered straight to your inbox.
x

By continuing to browse our site you agree to our use of cookies and our Privacy Policy.